Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-12-02 10:25 am Purchase | 13G | VIVEVE MED INC PAR $ VIVE | CVI Investments Inc. | 247,244 9.9% | 247,244 (New Position) | View |
| 2019-12-02 10:21 am Purchase | 13G | BIO-PATH HLDGS INC PAR $0. BPTH | CVI Investments Inc. | 202,020 5.5% | 202,020 (New Position) | View |
| 2019-11-01 09:32 am Purchase | 13G | OPGEN INC PAR $0.01 OPGN | CVI Investments Inc. | 200,000 5.8% | 200,000 (New Position) | View |
| 2019-08-23 09:59 am Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | CVI Investments Inc. | 675,000 8.5% | 675,000 (New Position) | View |
| 2019-08-09 09:39 am Purchase | 13G | ADAMIS PHARMACEUTICALS CORP CO ADMP | CVI Investments Inc. | 3,000,000 5.1% | 1,866,348 (+164.63%) | View |
| 2019-08-07 3:57 pm Purchase | 13G | XENETIC BIOSCIENCES INC PA XBIO | CVI Investments Inc. | 235,000 8.9% | 235,000 (New Position) | View |
| 2019-07-10 2:53 pm Purchase | 13G | VUZIX CORPORATION VUZI | CVI Investments Inc. | 2,739,727 8.3% | 2,739,727 (New Position) | View |
| 2019-06-28 09:56 am Purchase | 13G | SESEN BIO INC SESN | CVI Investments Inc. | 9,180,000 9.1% | 9,180,000 (New Position) | View |
| 2019-06-27 09:50 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | CVI Investments Inc. | 171,598 9.9% | 171,598 (New Position) | View |
| 2019-05-02 11:47 am Purchase | 13G | MOLECULIN BIOTECH INC MBRX | CVI Investments Inc. | 3,125,000 7.1% | 3,125,000 (New Position) | View |